These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

573 related items for PubMed ID: 16277683

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
    Stolt P, Källberg H, Lundberg I, Sjögren B, Klareskog L, Alfredsson L, EIRA study group.
    Ann Rheum Dis; 2005 Apr; 64(4):582-6. PubMed ID: 15319232
    [Abstract] [Full Text] [Related]

  • 5. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination.
    Klareskog L, Stolt P, Lundberg K, Källberg H, Bengtsson C, Grunewald J, Rönnelid J, Harris HE, Ulfgren AK, Rantapää-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L.
    Arthritis Rheum; 2006 Jan; 54(1):38-46. PubMed ID: 16385494
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis.
    Stolt P, Yahya A, Bengtsson C, Källberg H, Rönnelid J, Lundberg I, Klareskog L, Alfredsson L, EIRA Study Group.
    Ann Rheum Dis; 2010 Jun; 69(6):1072-6. PubMed ID: 19966090
    [Abstract] [Full Text] [Related]

  • 8. Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
    Bengtsson C, Nordmark B, Klareskog L, Lundberg I, Alfredsson L, EIRA Study Group.
    Ann Rheum Dis; 2005 Nov; 64(11):1588-94. PubMed ID: 15843455
    [Abstract] [Full Text] [Related]

  • 9. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    Lundström E, Källberg H, Smolnikova M, Ding B, Rönnelid J, Alfredsson L, Klareskog L, Padyukov L.
    Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
    [Abstract] [Full Text] [Related]

  • 10. Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study.
    Bengtsson C, Kapetanovic MC, Källberg H, Sverdrup B, Nordmark B, Klareskog L, Alfredsson L, EIRA Study Group.
    Ann Rheum Dis; 2010 Oct; 69(10):1831-3. PubMed ID: 20603497
    [Abstract] [Full Text] [Related]

  • 11. Usage of skin care products and risk of rheumatoid arthritis: results from the Swedish EIRA study.
    Sverdrup BM, Källberg H, Klareskog L, Alfredsson L, Epidemiological Investigation of Rheumatoid Arthritis Study Group.
    Arthritis Res Ther; 2012 Feb 28; 14(1):R41. PubMed ID: 22455933
    [Abstract] [Full Text] [Related]

  • 12. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.
    Scand J Rheumatol; 2008 Feb 28; 37(3):183-7. PubMed ID: 18465452
    [Abstract] [Full Text] [Related]

  • 13. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis.
    Mattey DL, Dawes PT, Clarke S, Fisher J, Brownfield A, Thomson W, Hajeer AH, Ollier WE.
    Arthritis Rheum; 2002 Aug 28; 47(4):403-7. PubMed ID: 12209487
    [Abstract] [Full Text] [Related]

  • 14. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark.
    Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, Pedersen BV, Wohlfahrt J, Frisch M.
    Arthritis Rheum; 2007 May 28; 56(5):1446-53. PubMed ID: 17469102
    [Abstract] [Full Text] [Related]

  • 15. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
    de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, Ronday HK, Kerstens PJ, Toes RE, de Vries RR, Breedveld FC, Dijkmans BA, Huizinga TW, Allaart CF.
    Arthritis Rheum; 2008 May 28; 58(5):1293-8. PubMed ID: 18438829
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden.
    Kokkonen H, Johansson M, Innala L, Jidell E, Rantapää-Dahlqvist S.
    Arthritis Res Ther; 2007 May 28; 9(3):R56. PubMed ID: 17553139
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.